Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pharma Legislation: From Pricing To Patents

Apr 03 2019

• By Brenda Sandburg

United States Capitol Building in Washington DC USA

Related Content

FDA Clears Zohydro Single-Entity Hydrocodone Without Abuse Deterrence Properties

Oct 25 2013

CREATES Act Has a Penalty Problem

Mar 28 2019

Bill To Revise US Subject Matter Patent Eligibility Standard Expected By 'Early Summer'

Mar 13 2019

House Drug Pricing Hearing Underscores Democrats' Challenges In Advancing Proposals

Mar 07 2019

Rebates Would Be Eliminated In Commercial Market Under Senate Bill

Mar 07 2019

Related Companies

Zogenix, Inc.

Additional Topics

United States Legislation Pricing Strategies Intellectual Property Policy FDA BioPharmaceutical

More from Legislation

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window